Anixa Biosciences, Inc.
ANIX
$3.38
-$0.17-4.79%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15.60M | 17.26M | 19.92M | 20.75M | 23.24M |
| Total Receivables | -- | -- | 173.00K | 410.00K | 218.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.17M | 1.43M | 1.27M | 1.52M | 757.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 16.77M | 18.69M | 21.36M | 22.67M | 24.21M |
|
|
|||||
| Total Current Assets | 16.77M | 18.69M | 21.36M | 22.67M | 24.21M |
| Net Property, Plant & Equipment | 211.00K | 220.00K | 229.00K | 238.00K | 141.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 16.98M | 18.91M | 21.59M | 22.91M | 24.36M |
|
|
|||||
| Total Accounts Payable | 284.00K | 600.00K | 525.00K | 302.00K | 215.00K |
| Total Accrued Expenses | 1.57M | 1.36M | 1.95M | 1.68M | 1.41M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 37.00K | 36.00K | 29.00K | 24.00K | 56.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.89M | 2.00M | 2.50M | 2.00M | 1.68M |
|
|
|||||
| Total Current Liabilities | 1.89M | 2.00M | 2.50M | 2.00M | 1.68M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 184.00K | 194.00K | 203.00K | 213.00K | 93.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.07M | 2.19M | 2.70M | 2.22M | 1.77M |
|
|
|||||
| Common Stock & APIC | 262.79M | 261.79M | 260.75M | 259.64M | 258.21M |
| Retained Earnings | -246.72M | -243.93M | -240.75M | -237.87M | -234.59M |
| Treasury Stock & Other | -- | -6.00K | -6.00K | -- | -- |
| Total Common Equity | 16.07M | 17.85M | 20.00M | 21.77M | 23.62M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 16.07M | 17.85M | 20.00M | 21.77M | 23.62M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -1.16M | -1.14M | -1.11M | -1.08M | -1.04M |
| Total Equity | 14.91M | 16.71M | 18.89M | 20.69M | 22.58M |
|
|
|||||